ISRCTN10323655已完成不适用
Evaluation of efficacy of moxifloxacin (0.5%) in the treatment of non-perforated bacterial corneal ulcers: a randomised controlled trial
Rajendra Prasad Centre for Ophthalmic Sciences (India)0 个研究点目标入组 150 人开始时间: 2010年8月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Non-perforated bacterial corneal ulcers
排除标准
- •1. Known allergy to fluoroquinolones, aminoglycosides, penicillins,cephalosporins or benzalkoniun chloride
- •2. Patients with fungal, viral or acanthamoeba infection
- •3. Patients to be treated with subconjuctival injection(s) of antibiotic(s) and/or with systemic antimicrobials
- •4. Patients aged 16 - 65 years
- •5. Pregnant and lactating females
- •6. Any adverse effects or protocol violations
- •7. Perforated corneal ulcers
研究者
相似试验
已完成
3 期
Clinical efficacy of Moxifloxacin in the treatment of Bacterial Keratitis: A Randomised Clinical TrialBacterial KeratitisEye - Diseases / disorders of the eyeACTRN12606000406505Centre for Eye Research Australia229
进行中（未招募）
1 期
Pharmacokinetic evaluation of moxifloxacin administered intravenously and orally in healthy volunteers who have had a gastric bypass.Healthy volunteers who have had a gastric bypass at least 6 months agoEUCTR2010-018628-14-BEniversity Ghent
尚未招募
3 期
Evaluation of moxifloxacin effevtiveness in wound healingIRCT20181208041882N5Yazd University of Medical Sciences80
尚未招募
4 期
Evaluation of Gatifloxacin in treatment of bacterial corneal ulcersCTRI/2015/05/005781RPC AIIMS200
已完成
3 期
An Evaluation of the Safety and Efficacy of Moxifloxacin Ophthalmic Solution 0.5% ((VIGAMOX®) Versus Ofloxacin Ophthalmic Solution 0.3% in the Treatment of Bacterial Conjunctivitis in Chinese PatientsBacterial ConjunctivitisNCT01573910Alcon Research985